4.6 Article

Tumor-infiltrating neutrophils predict therapeutic benefit of tyrosine kinase inhibitors in metastatic renal cell carcinoma

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

An Immune Atlas of Clear Cell Renal Cell Carcinoma

Stephane Chevrier et al.

Review Peripheral Vascular Disease

Anti-angiogenesis for cancer revisited: Is there a role for combinations with immunotherapy?

Rakesh R. Ramjiawan et al.

ANGIOGENESIS (2017)

Article Biochemical Research Methods

Robust enumeration of cell subsets from tissue expression profiles

Aaron M. Newman et al.

NATURE METHODS (2015)

Editorial Material Biochemical Research Methods

FunRich proteomics software analysis, let the fun begin!

Alberto Benito-Martin et al.

PROTEOMICS (2015)

Review Pharmacology & Pharmacy

The Great Escape; the Hallmarks of Resistance to Antiangiogenic Therapy

Judy R. van Beijnum et al.

PHARMACOLOGICAL REVIEWS (2015)

Article Medicine, Research & Experimental

Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer

Evgeniy B. Eruslanov et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Article Pathology

The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia

John R. Srigley et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Article Multidisciplinary Sciences

Oncogenic RAS pathway activation promotes resistance to anti-VEGF therapy through G-CSF-induced neutrophil recruitment

Vernon T. Phan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Review Immunology

Modulation of Immunity by Antiangiogenic Molecules in Cancer

Magali Terme et al.

CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)

Article Gastroenterology & Hepatology

Intratumoral neutrophils: A poor prognostic factor for hepatocellular carcinoma following resection

Yi-Wei Li et al.

JOURNAL OF HEPATOLOGY (2011)

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Review Oncology

Resistance to targeted therapy in renal-cell carcinoma

Brian I. Rini et al.

LANCET ONCOLOGY (2009)

Review Pharmacology & Pharmacy

Tumor and stromal pathways mediating refractoriness/resistance to anti-angiogenic therapies

Yongping Crawford et al.

TRENDS IN PHARMACOLOGICAL SCIENCES (2009)

Article Multidisciplinary Sciences

Bv8 regulates myeloid-cell-dependent tumour angiogenesis

Farbod Shojaei et al.

NATURE (2007)

Article Biotechnology & Applied Microbiology

Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells

Farbod Shojaei et al.

NATURE BIOTECHNOLOGY (2007)

Article Medicine, General & Internal

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

Robert J. Motzer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Oncology

Impact of immune parameters on long-term survival in metastatic renal cell carcinoma

F Donskov et al.

JOURNAL OF CLINICAL ONCOLOGY (2006)